The invention provides .beta..sub.3-adrenoreceptor agonists,
pharmaceutical compositions comprising .beta..sub.3-adrenoreceptor
agonist compounds, and methods of using such compounds for stimulating,
regulating or modulating metabolism of fats in adipose tissue in animals.